Citations

Showing 10 of 108083 citations.

Continuous positive airway pressure device–associated nonhealing ulcer on the nasal dorsum: chondrodermatitis nodularis nasi
Reinhart, Jacob P. , Isaq, Nasro A., Peters, Margot S. , Vidal, Nahid Y. , Reinhart, Jacob

Mayo Clinic

Journal of Clinical Sleep Medicine | February 15, 2023 | Volume: 19 | Issue: 6 | Pages: 1157-1159

10.5664/jcsm.10518 | PMID 36789880 Get It

Determinants of Professional Fulfillment and Burnout Among Intensivists: A National Survey by the Society of Critical Care Anesthesiologists in 2022
Siddiqui, Shahla , Monteith, Erika, Shaefi, Shahzad , Tung, Avery , Sladen, Robert N. , Warner, Matthew A. , Kelly, Lauren, Douin, David J. , Mladinov, Domagoj , Stevens, Robert David , Siddiqui, Shahla

Mayo Clinic

Anesthesia & Analgesia | February 15, 2023 | Volume: 137 | Issue: 2 | Pages: 375-382

10.1213/ane.0000000000006384 | PMID 36791019 Get It

BACKGROUND: Increased burnout and decreased professional fulfillment among intensive care physicians is partly due to intensive care unit (ICU) workload. Although the SARS-CoV-2 (COVID-19) pandemic increased ICU workload, it also may have increased feelings of personal fulfillment due to positive public perceptions of physicians caring for COVID patients. We surveyed critical care anesthesiologists to identify the effect of provider demographics, ICU workload, and COVID-19–related workload, on professional fulfillment and burnout. METHODS: We performed an exploratory survey of 606 members of the Society of Critical Care Anesthesiologists (SOCCA) in January and February 2022. We used the Stanford Professional Fulfillment Index (PFI) to grade levels of professional fulfillment and markers of burnout (ie, work exhaustion and disengagement). Univariable and multivariable models were used to identify associations between provider demographics and practice characteristics and professional fulfillment and work exhaustion. RESULTS: One hundred and seventy-five intensivists (29%) responded. A total of 65% were male and 49% were between 36 and 45 years old. The overall median PFI score—0 (none) to 24 (most professional fulfillment)—was 17 (IQR, 1–24), with a wide distribution of responses. In multivariable analysis, factors associated with higher professional fulfillment included age >45 years ( P =.004), ≤15 weeks full-time ICU coverage in 2020 ( P =.02), role as medical director ( P =.01), and nighttime home call with supervision of in-house ICU fellows ( P =.01). CONCLUSIONS: Professional fulfillment and work exhaustion in this cross-sectional survey were associated with several demographic and practice characteristics but not COVID-19–related workload, suggesting that COVID-19 workload may not have either positive or negative perceptions on professional fulfillment.
Cover Image, Volume 6, Issue 2
Giorgakis, Emmanouil , Wells, Allison, Balogh, Julius , Krinock, Derek , Burdine, Lyle , Singer, Andrew L., Mathur, Amit K. , Giorgakis, Emmanouil , Balogh, Julius , Ivanics, Tommy , Wallace, David , Hardgrave, Hailey , Klutts, Garrett N.

Mayo Clinic

Health Science Reports | February 15, 2023 | Volume: 6 | Issue: 2 | Pages: No page available

10.1002/hsr2.1125 Get It

Clinical and histopathological features of hypereosinophilic syndrome with cutaneous involvement: The Mayo Clinic Experience
Zayas, Jacqueline , Peters, Margot S. , Butterfield, Joseph H. , Pongdee, Thanai , Sokumbi, Olayemi , Sokumbi, Olayemi

Mayo Clinic

Journal of Cutaneous Pathology | February 15, 2023 | Volume: 50 | Issue: 5 | Pages: 455-465

10.1111/cup.14410 | PMID 36790036 Get It

AbstractBackgroundHypereosinophilic syndrome (HES) encompasses a group of diseases with blood hypereosinophilia and eosinophil‐mediated organ dysfunction. HES‐associated skin abnormalities, termed cutaneous HES (cHES) here, may influence diagnosis of HES. We sought to better define clinical and histopathological features of cHES.MethodsWe retrospectively reviewed clinical records and cutaneous histopathology of adult patients with HES evaluated at our institution from 2007 to 2018.ResultsForty‐one percent (61/150) patients with HES had cHES. The most common clinical morphologies were urticarial (30%) and eczematous (26%). Skin specimens most often showed a spongiotic pattern (31%) with abundant inflammation (50%) including eosinophils (85%). Two specimens (8%) showed interstitial granulomatous dermatitis, and two specimens showed eosinophilic fasciitis (8%). Vasculitis was not identified in any specimen. Eighty‐four percent of patients with cHES had ≥1 other organ system involved: pulmonary 41%, ENT 26%, and nervous 23%. Sixty percent (53/89) of non‐cHES patients had at least two organ systems involved. Cardiac or gastrointestinal involvement was more common in non‐cHES than cHES (p < 0.05).ConclusionOur review confirms that there are no specific clinical or histopathological cHES patterns, but HES should be considered in patients who have eczematous or urticarial reactions of unknown etiology and persistent peripheral hypereosinophilia.
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Wang, Chen , Block, Matthew S. , Cunningham, Julie M. , Sherman, Mark E. , McCauley, Bryan M. , Armasu, Sebastian M. , Vierkant, Robert A. , Group, for the Australian Ovarian Cancer Study, Talhouk, Aline , Ramus, Susan J. , Pejovic, Nadja , Jorgensen, Brooke D. , Garsed, Dale W. , Anglesio, Michael S. , Widschwendter, Martin , Bowtell, David D.L. , Goode, Ellen L. , Traficante, Nadia , Talhouk, Aline , Ramus, Susan J , Pejovic, Nadja , Köbel, Martin , Jorgensen, Brooke D , Garsed, Dale W , Fereday, Sian , Doherty, Jennifer A , Ariyaratne, Dinuka , Anglesio, Michael S , Widschwendter, Martin , Pejovic, Tanja B. , Bosquet, Jesus Gonzalez , Bowtell, David D , Winham, Stacey J , Goode, Ellen L , Vierkant, Robert A , Wang, Chen , Sherman, Mark E , Traficante, Nadia , Group, for the Australian Ovarian Cancer Study, Köbel, Martin , Fereday, Sián , Doherty, Jennifer A. , Ariyaratne, Dinuka , Bosquet, Jesús González , Winham, Stacey J.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | February 15, 2023 | Volume: 32 | Issue: 4 | Pages: 542-549

10.1158/1055-9965.epi-22-0941 | PMID 36790339 Get It

Abstract Background: Better understanding of prognostic factors in tubo-ovarian high-grade serous carcinoma (HGSC) is critical, as diagnosis confers an aggressive disease course. Variation in tumor DNA methylation shows promise predicting outcome, yet prior studies were largely platform-specific and unable to evaluate multiple molecular features. Methods: We analyzed genome-wide DNA methylation in 1,040 frozen HGSC, including 325 previously reported upon, seeking a multi-platform quantitative methylation signature that we evaluated in relation to clinical features, tumor characteristics, time to recurrence/death, extent of CD8+ tumor-infiltrating lymphocytes (TIL), gene expression molecular subtypes, and gene expression of the ATP-binding cassette transporter TAP1. Results: Methylation signature was associated with shorter time to recurrence, independent of clinical factors (N = 715 new set, hazard ratio (HR), 1.65; 95% confidence interval (CI), 1.10–2.46; P = 0.015; N = 325 published set HR, 2.87; 95% CI, 2.17–3.81; P = 2.2 × 10−13) and remained prognostic after adjustment for gene expression molecular subtype and TAP1 expression (N = 599; HR, 2.22; 95% CI, 1.66–2.95; P = 4.1 × 10−8). Methylation signature was inversely related to CD8+ TIL levels (P = 2.4 × 10−7) and TAP1 expression (P = 0.0011) and was associated with gene expression molecular subtype (P = 5.9 × 10−4) in covariate-adjusted analysis. Conclusions: Multi-center analysis identified a novel quantitative tumor methylation signature of HGSC applicable to numerous commercially available platforms indicative of shorter time to recurrence/death, adjusting for other factors. Along with immune cell composition analysis, these results suggest a role for DNA methylation in the immunosuppressive microenvironment. Impact: This work aids in identification of targetable epigenome processes and stratification of patients for whom tailored treatment may be most beneficial.
New Editor‐in‐Chief introduction
Jensen, Michael D.

Mayo Clinic

Obesity | February 15, 2023 | Volume: 31 | Issue: 3 | Pages: 593-593

10.1002/oby.23718 Get It

Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy
Khouzam, Raefa Abou , Lehn, Jean‐Maríe , Mayr, Hemma , Clavien, Pierre‐Alain , Wallace, Michael B. , Ducreux, Michel , Limani, Përparim , Chouaı̈b, Salem , Abou Khouzam, Raefa , Wallace, Michael B

Mayo Clinic

Cancers | February 15, 2023 | Volume: 15 | Issue: 4 | Pages: 1235

10.3390/cancers15041235 | PMID 36831579 Get It

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, and it is a disease of dismal prognosis. While immunotherapy has revolutionized the treatment of various solid tumors, it has achieved little success in PDAC. Hypoxia within the stroma-rich tumor microenvironment is associated with resistance to therapies and promotes angiogenesis, giving rise to a chaotic and leaky vasculature that is inefficient at shuttling oxygen and nutrients. Hypoxia and its downstream effectors have been implicated in immune resistance and could be contributing to the lack of response to immunotherapy experienced by patients with PDAC. Paradoxically, increasing evidence has shown hypoxia to augment genomic instability and mutagenesis in cancer, suggesting that hypoxic tumor cells could have increased production of neoantigens that can potentially enable their clearance by cytotoxic immune cells. Strategies aimed at relieving this condition have been on the rise, and one such approach opts for normalizing the tumor vasculature to reverse hypoxia and its downstream support of tumor pathogenesis. An important consideration for the successful implementation of such strategies in the clinic is that not all PDACs are equally hypoxic, therefore hypoxia-detection approaches should be integrated to enable optimal patient selection for achieving improved patient outcomes.
Using a web-based digital simulation to foster empathy for older adults with visual impairments
Parks, Margaret, Kim, Daejin

Mayo Clinic

Educational Gerontology | February 15, 2023 | Volume: 49 | Issue: 11 | Pages: 937-946

10.1080/03601277.2023.2180205 Get It

Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease
Caldera, Freddy , Richard, Luke J., Almasry, Mazen, Phan, Hiep , Chun, Kelly , Caldera, Freddy , Farraye, Francis A. , Hayney, Mary S.

Mayo Clinic

Inflammatory Bowel Diseases | February 15, 2023 | Volume: 29 | Issue: 10 | Pages: 1662-1666

10.1093/ibd/izad019 | PMID 36788133 Get It

Lay Summary We evaluated antibody concentrations 6 months after a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. Almost all patients had an antibody response, and those with a previous SARS-CoV-2 infection had higher antibody concentrations.
Pulmonary Vascular Disease in Heart Failure with Preserved Ejection Fraction: The Evidence Grows
Abbasi, Muhannad , Abbasi, Muhannad A, Borlaug, Barry A.

Mayo Clinic

European Journal of Heart Failure | February 15, 2023 | Volume: 25 | Issue: 3 | Pages: 332-334

10.1002/ejhf.2800 | PMID 36789637 Get It